Expression	O
of	O
HER2	O
and	O
bradykinin	O
B1	O
receptors	O
in	O
precursor	B-Pathological_formation
lesions	I-Pathological_formation
of	O
gallbladder	B-Cancer
carcinoma	I-Cancer
.	O

AIM	O
:	O
To	O
determine	O
the	O
expression	O
of	O
HER2	O
and	O
bradykinin	O
B	O
(	O
1	O
)	O
receptors	O
(	O
B	O
(	O
1	O
)	O
R	O
)	O
in	O
the	O
two	O
pathogenic	O
models	O
of	O
gallbladder	B-Cancer
cancer	I-Cancer
:	O
the	O
metaplasia	B-Cancer
-	I-Cancer
dysplasia	I-Cancer
-	I-Cancer
carcinoma	I-Cancer
and	O
the	O
adenoma	B-Cancer
-	I-Cancer
carcinoma	I-Cancer
pathways	O
.	O

METHODS	O
:	O
Receptor	O
proteins	O
were	O
visualized	O
by	O
immunohistochemistry	O
on	O
5	O
-	O
mum	O
sections	B-Multi-tissue_structure
of	O
paraffin	O
-	O
embedded	O
tissue	B-Tissue
.	O

Expression	O
of	O
both	O
receptors	O
was	O
studied	O
in	O
biopsy	B-Cancer
samples	I-Cancer
from	O
92	O
patients	O
(	O
6	O
males	O
and	O
86	O
females	O
;	O
age	O
ranging	O
from	O
28	O
to	O
86	O
years	O
,	O
mean	O
56	O
years	O
)	O
.	O

High	O
HER2	O
expression	O
in	O
specimens	B-Cancer
was	O
additionally	O
investigated	O
by	O
fluorescence	O
in	O
situ	O
hybridization	O
.	O

Cell	B-Cell
proliferation	O
in	O
each	O
sample	B-Cancer
was	O
assessed	O
by	O
using	O
the	O
Ki	O
-	O
67	O
proliferation	O
marker	O
.	O

RESULTS	O
:	O
HER2	O
receptor	O
protein	O
was	O
absent	O
in	O
adenomas	B-Cancer
and	O
in	O
normal	O
gallbladder	B-Tissue
epithelium	I-Tissue
.	O

On	O
the	O
contrary	O
,	O
there	O
was	O
intense	O
staining	O
for	O
HER2	O
on	O
the	O
basolateral	B-Cellular_component
membrane	I-Cellular_component
of	O
epithelial	B-Cell
cells	I-Cell
of	O
intestinal	B-Pathological_formation
metaplasia	I-Pathological_formation
(	O
22	O
/	O
24	O
;	O
91	O
.	O
7	O
%	O
)	O
and	O
carcinoma	B-Cancer
in	I-Cancer
situ	I-Cancer
(	O
9	O
/	O
10	O
;	O
90	O
%	O
)	O
,	O
the	O
lesions	B-Pathological_formation
that	O
displayed	O
a	O
significantly	O
high	O
proliferation	O
index	O
.	O

Protein	O
up	O
-	O
regulation	O
of	O
HER2	O
in	O
the	O
epithelium	B-Tissue
with	O
metaplasia	B-Pathological_formation
or	O
carcinoma	B-Cancer
in	I-Cancer
situ	I-Cancer
was	O
not	O
accompanied	O
by	O
HER2	O
gene	O
amplification	O
.	O

A	O
similar	O
result	O
was	O
observed	O
in	O
invasive	B-Cancer
carcinomas	I-Cancer
(	O
0	O
/	O
12	O
)	O
.	O

The	O
B	O
(	O
1	O
)	O
R	O
distribution	O
pattern	O
mirrored	O
that	O
of	O
HER2	O
except	O
that	O
B	O
(	O
1	O
)	O
R	O
was	O
additionally	O
observed	O
in	O
the	O
adenomas	B-Cancer
.	O

The	O
B	O
(	O
1	O
)	O
R	O
appeared	O
either	O
as	O
cytoplasmic	B-Organism_substance
dots	O
or	O
labeling	O
on	O
the	O
apical	B-Cellular_component
cell	I-Cellular_component
membrane	I-Cellular_component
of	O
the	O
cells	B-Cell
composing	O
the	O
epithelia	B-Tissue
with	O
intestinal	B-Pathological_formation
metaplasia	I-Pathological_formation
(	O
24	O
/	O
24	O
;	O
100	O
%	O
)	O
and	O
carcinoma	B-Cancer
in	I-Cancer
situ	I-Cancer
(	O
10	O
/	O
10	O
;	O
100	O
%	O
)	O
and	O
in	O
the	O
epithelial	B-Cell
cells	I-Cell
of	O
adenomas	B-Cancer
.	O

In	O
contrast	O
,	O
both	O
HER2	O
(	O
4	O
/	O
12	O
;	O
33	O
%	O
)	O
and	O
B	O
(	O
1	O
)	O
R	O
(	O
1	O
/	O
12	O
;	O
8	O
.	O
3	O
%	O
)	O
showed	O
a	O
low	O
expression	O
in	O
invasive	B-Cancer
gallbladder	I-Cancer
carcinomas	I-Cancer
.	O

CONCLUSION	O
:	O
The	O
up	O
-	O
regulation	O
of	O
HER2	O
and	O
B	O
(	O
1	O
)	O
R	O
in	O
precursor	B-Pathological_formation
lesions	I-Pathological_formation
of	O
gallbladder	B-Cancer
carcinoma	I-Cancer
suggests	O
cross	O
-	O
talk	O
between	O
these	O
two	O
receptors	O
that	O
may	O
be	O
of	O
importance	O
in	O
the	O
modulation	O
of	O
cell	B-Cell
proliferation	O
in	O
gallbladder	B-Organ
carcinogenesis	O
.	O

